Student will scale peak to send diabetes message, do research

November 15, 2000

CHAPEL HILL -- On Jeremy Ackerman's 15th birthday, he learned that he had diabetes. His parents were dismayed, but young Ackerman set out to learn more about the disease and to learn how to manage it so he could still do the things he wanted to do.

He strongly believes that people with diabetes -- especially younger ones -- need to know that the disease, while serious, doesn't have to limit them and that they "can do almost anything they want." To make that point, he and 15 other Type 1 diabetic athletes from around the world will travel to Argentina Dec. 26 to climb Cerro Aconcagua, which, with a summit of 22,830 feet, is the highest point in the Western Hemisphere.

Eleven years after the diagnosis, the Maryland native is a University of North Carolina M.D.-Ph.D. candidate with aspirations to surgery and a graduate degree in biomedical engineering. But he still finds time for the outdoor activities he loves. He's an experienced backpacker and trekker and has even dabbled in rock climbing -- all this while successfully managing his glucose levels.

Ackerman, who admits that he was something of a terror to doctors in the early years of his disease, is now better able to understand doctor and family concerns about diabetes management. A founding member of the group, IDEA2000 -- or the International Diabetic Expedition to Aconcagua - the medical student says the goal of the ambitious project, which has been in the planning stages for more than two years, is three-fold.

"We want to raise awareness of diabetes and to inspire diabetics to achieve their goals," he says. "We want to raise $2.1 million to support diabetes care in underserved parts of Latin America, and, while we're doing all this, conduct scientific research on altitude's effects on diabetics and diabetes management."

The experience should also be a lot of fun, he says. Group members traveling to Argentina represent a variety of mountaineering skill levels, according to Ackerman.

"A few are like me with a limited amount of experience. Others are very experienced mountaineers, like the director of the group and another climber from Spain," he says. "That's why there will be two teams heading up the mountain -- the 'summiting' group doing a challenging technical climb and the less experienced 'trekking' group following a non-technical route supporting the other climbers and the research effort.

What members have in common is their understanding of their disease, Ackerman says. "Most of us are aware that you can do just about anything when you have diabetes. The hard part is knowing what issues to address and plan for. For example, insulin can freeze, which not only makes it impossible to inject but also renders it less effective. Insulin also stops working if it gets too warm."

When the small electronic blood glucose meter used to measure sugar levels is taken to higher altitudes, the chemistry of the device changes. LCD displays and batteries present in watches, blood glucose meters and insulin pumps also are sensitive to the cold -- potentially affecting insulin delivery and diabetes management. Climbers worry about their insulin pumps failing much more than their watches.

"When you get into the mountains, there's a whole range of effects on your physiology," Ackerman says. "There are all these factors, some not completely understood, that interact with diabetes. We have to decide how to control variables like how much insulin to take, how much food to eat and how much activity we can do. Some things we do from experience, and sometimes, we have to guess what will happen."

As the project evolved, IDEA2000 came up with programs for tax-deductible donations, including sales of special T-shirts (delivered personally by Ackerman to save shipping costs to buyers). In addition, donors of $10 or more will be sent a postcard from the team in Argentina. Those who donate $100 or more will receive a prayer flag, which is like the small, lightweight flags mountaineers carry. "The idea is that we're carrying your hopes and dreams with us," he adds.
-end-
For more information, call Ackerman at (919) 967-2146 or e-mail him at ackerman@cs.unc.edu. The project's Web address is www.idea2000.org.

Contact: David Williamson, (919) 962-8596.

University of North Carolina at Chapel Hill

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.